Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HMGCR | P04035 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | ACLY | P53396 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ACACB | O00763 | 1/20 | 0.35 |
| ▸ | ACACA | Q13085 | 1/20 | 0.35 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | CPT2 | P23786 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19318312 | 0.79 | ACLY (0.39) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 | |
| SCHEMBL8197662 | 0.79 | ACLY (0.39) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 | |
| SCHEMBL12595360 | 0.78 | KMT2A (0.32) | TSHRCYP2D6CYP2C19HIF1AHMGCR | |
| SCHEMBL83915 | 0.77 | TSHR (0.60) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 | |
| Hydrochloric Acid SCHEMBL4137653 | 0.77 | TSHR (0.60) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 | |
| SCHEMBL25269996 | 0.77 | TSHR (0.46) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 | |
| SCHEMBL377850 | 0.76 | KMT2A (0.31) | HMGCRCHRM1TBXA2RADRA1AKMT2A | |
| SCHEMBL26607633 | 0.76 | ALDH1A1 (0.55) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 | |
| SCHEMBL28478983 | 0.74 | TSHR (0.57) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 | |
| SCHEMBL243901 | 0.74 | TSHR (0.43) | TSHRCYP2D6CYP2C19HIF1AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230233526-A1 | GRANZYME B INHIBITOR COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF SKIN BLISTERING AND/OR PEELING | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2023-07-27 | — | — | US | disclosed |
| US-11478417-B2 | Fragrance product | AKI, INC. (US) | 2022-10-25 | — | — | US | disclosed |
| US-9969772-B2 | Covalent granzyme B inhibitors | VIDA THERAPEUTICS INC. (CA) | 2018-05-15 | — | — | US | disclosed |
| US-9969770-B2 | Proline compounds as Granzyme B inhibitors | VIDA THERAPEUTICS INC. (CA) | 2018-05-15 | — | — | US | disclosed |
| US-9849112-B2 | Pyrrole compounds as Granzyme B inhibitors | VIDA THERAPEUTICS INC. (CA) | 2017-12-26 | — | — | US | disclosed |
| US-20170348324-A1 | DERIVATIVES OF BETULIN | GLAXOSMITHKLINE LLC (US) | 2017-12-07 | — | — | US | disclosed |
| US-20170252356-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING HIV WITH DERIVATIVES OF BETULIN | GLAXOSMITHKLINE LLC | 2017-09-07 | — | — | US | disclosed |
| US-20170252356-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING HIV WITH DERIVATIVES OF BETULIN | GLAXOSMITHKLINE LLC | 2017-09-07 | — | — | US | disclosed |
| US-20170218014-A1 | AZAINDOLINE COMPOUNDS AS GRANZYME B INHIBITORS | VIDA THERAPEUTICS INC. (CA) | 2017-08-03 | — | — | US | disclosed |
| US-20170015706-A1 | PROLINE COMPOUNDS AS GRANZYME B INHIBITORS | VIDA THERAPEUTICS INC. (CA) | 2017-01-19 | — | — | US | disclosed |
| US-20160120878-A1 | DERIVATIVES OF BETULIN | GLAXOSMITHKLINE LLC | 2016-05-05 | — | — | US | disclosed |
| US-9102685-B2 | Derivatives of betulin | GLAXOSMITHKLINE LLC (US) | 2015-08-11 | — | — | US | disclosed |
| US-20150218142-A1 | Derivatives of Betulin | GLAXOSMITHKLINE LLC (US) | 2015-08-06 | — | — | US | disclosed |
| US-20140357643-A1 | Derivatives of Betulin | GLAXOSMITHKLINE LLC | 2014-12-04 | — | — | US | disclosed |
| US-20140350032-A1 | PROPENOATE DERIVATIVES OF BETULIN | GLAXOSMITHKLINE LLC | 2014-11-27 | — | — | US | disclosed |
| US-20130184263-A1 | Derivatives of Betulin | GLAXOSMITHKLINE LLC (US) | 2013-07-18 | — | — | US | disclosed |
| EP-2220094-A1 | NOVEL INTERMEDIATE FOR HALICHONDRIN B ANALOG SYNTHESIS AND NOVEL DESULFONYLATION REACTION USED FOR THE INTERMEDIATE | Eisai R&D Management Co., Ltd. (JP) | 2010-08-25 | — | — | EP | disclosed |
| US-7645771-B2 | CCR5 antagonists as therapeutic agents | SMITHKLINE BEECHAM CORP. (US) | 2010-01-12 | — | — | US | disclosed |
| US-20090203771-A1 | NOVEL INTERMEDIATE FOR HALICHONDRIN B ANALOG SYNTHESIS AND NOVEL DESULFONYLATION REACTION USED FOR THE INTERMEDIATE | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2009-08-13 | — | — | US | disclosed |
| WO-2009064029-A1 | NOVEL INTERMEDIATE FOR HALICHONDRIN B ANALOG SYNTHESIS AND NOVEL DESULFONYLATION REACTION USED FOR THE INTERMEDIATE | EISAI R & D MANAGEMENT CO., LTD. (JP) | 2009-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140350032-A1 | PROPENOATE DERIVATIVES OF BETULIN | BET1, TMPO, PGGT1B | TSHR 4572/4885CYP2D6 2081/4885CYP2C19 1728/4885 |
| US-20170252356-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING HIV WITH DERIVATIVES OF BETULIN | BET1, PGGT1B, TMPO | TSHR 4871/4885CYP2D6 2880/4885CYP2C19 2194/4885 |
| US-20170218014-A1 | AZAINDOLINE COMPOUNDS AS GRANZYME B INHIBITORS | GZMB, DNASE1L3, DNASE1 | TSHR 4232/4885CYP2D6 4297/4885CYP2C19 3775/4885 |
| US-11478417-B2 | Fragrance product | CUTA, SORD, RER1 | TSHR 4181/4885CYP2D6 968/4885CYP2C19 1178/4885 |
| US-20170348324-A1 | DERIVATIVES OF BETULIN | BET1, TMPO, PGGT1B | TSHR 4559/4885CYP2D6 1932/4885CYP2C19 2084/4885 |
| US-20140357643-A1 | Derivatives of Betulin | BET1, TMPO, PGGT1B | TSHR 4559/4885CYP2D6 1932/4885CYP2C19 2084/4885 |
| US-20130184263-A1 | Derivatives of Betulin | BET1, PGGT1B, TMPO | TSHR 4549/4885CYP2D6 2034/4885CYP2C19 2392/4885 |
| US-20090203771-A1 | NOVEL INTERMEDIATE FOR HALICHONDRIN B ANALOG SYNTHESIS AND NOVEL DESULFONYLATION REACTION USED FOR THE INTERMEDIATE | NISCH, BMP2, SHH | TSHR 2474/4885CYP2D6 3361/4885CYP2C19 2957/4885 |
| US-20230233526-A1 | GRANZYME B INHIBITOR COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF SKIN BLISTERING AND/OR PEELING | GZMB, SERPINB1, CTSB | TSHR 4811/4885CYP2D6 4460/4885CYP2C19 2829/4885 |
| US-20160120878-A1 | DERIVATIVES OF BETULIN | BET1, PGGT1B, TMPO | TSHR 4549/4885CYP2D6 2034/4885CYP2C19 2392/4885 |
| US-20170015706-A1 | PROLINE COMPOUNDS AS GRANZYME B INHIBITORS | GZMB, CTSB, RNPEP | TSHR 4338/4885CYP2D6 4563/4885CYP2C19 3590/4885 |
| US-20150218142-A1 | Derivatives of Betulin | BET1, PGGT1B, TMPO | TSHR 4549/4885CYP2D6 2034/4885CYP2C19 2392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.